These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1925547)

  • 1. Receptor-mediated activation of immunodeficiency viruses in viral fusion.
    Allan JS
    Science; 1991 May; 252(5010):1322-3. PubMed ID: 1925547
    [No Abstract]   [Full Text] [Related]  

  • 2. Human and simian immunodeficiency viruses: virus-receptor interactions.
    Signoret N; Poignard P; Blanc D; Sattentau QJ
    Trends Microbiol; 1993 Dec; 1(9):328-33. PubMed ID: 8162421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
    Hsu M; Harouse JM; Gettie A; Buckner C; Blanchard J; Cheng-Mayer C
    J Virol; 2003 Jan; 77(2):989-98. PubMed ID: 12502815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4-independent binding of SIV gp120 to rhesus CCR5.
    Martin KA; Wyatt R; Farzan M; Choe H; Marcon L; Desjardins E; Robinson J; Sodroski J; Gerard C; Gerard NP
    Science; 1997 Nov; 278(5342):1470-3. PubMed ID: 9367961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giving HIV a dose of its own medicine.
    Bonetta L
    Nat Med; 1998 Jan; 4(1):17. PubMed ID: 9427597
    [No Abstract]   [Full Text] [Related]  

  • 6. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.
    Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A
    J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4.
    Ivey-Hoyle M; Culp JS; Chaikin MA; Hellmig BD; Matthews TJ; Sweet RW; Rosenberg M
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):512-6. PubMed ID: 1899141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a binding site for human immunodeficiency virus type 1 gp120 in rat CD4.
    Schockmel GA; Somoza C; Davis SJ; Williams AF; Healey D
    J Exp Med; 1992 Jan; 175(1):301-4. PubMed ID: 1730924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CD4 in HIV binding and entry.
    Sattentau QJ; Moore JP
    Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):59-66. PubMed ID: 7904348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope.
    Johnson WE; Morgan J; Reitter J; Puffer BA; Czajak S; Doms RW; Desrosiers RC
    J Virol; 2002 Mar; 76(5):2075-86. PubMed ID: 11836385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.
    Bannert N; Schenten D; Craig S; Sodroski J
    J Virol; 2000 Dec; 74(23):10984-93. PubMed ID: 11069993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fiery entrance for the HIV co-receptor.
    Thompson C
    Lancet; 1994 Jan; 343(8888):49. PubMed ID: 7905055
    [No Abstract]   [Full Text] [Related]  

  • 15. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
    Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
    J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
    Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
    Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
    J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 antagonists.
    McKeating JA
    Biochem Soc Trans; 1992 May; 20(2):521-5. PubMed ID: 1397653
    [No Abstract]   [Full Text] [Related]  

  • 19. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.